Tolterodine
Back to searchMolecule Structure
Scientific Name
Tolterodine
Description of the Drug
Tolterodine is a muscarinic receptor antagonist used to treat overactive bladder with urinary incontinence, urgency, and frequency.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01036
http://www.drugbank.ca/drugs/DB01036
Brand Name(s)
Blerone xl, Detrusitol, Detrusitol xl, Efflosomyl xl, Inconex xl, Mariosea xl, Neditol xl, Preblacon xl, Santizor xl
Company Owner(s)
Apotex Corp, Athem Holdings Llc, Ajanta Pharma Ltd, Upjohn Us 2 Llc, Macleods Pharmaceuticals Ltd, Unique Pharmaceutical Laboratories A Division Of J.B. Chemicals And Pharmaceuticals Ltd, Hetero Labs Ltd Unit Iii, Amta Labs Ltd, Teva Pharmaceuticals Usa, Hetero Labs Ltd Unit V
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Muscarinic acetylcholine receptor M3 | SINGLE PROTEIN | ANTAGONIST | CHEMBL245 |
| Muscarinic acetylcholine receptor M2 | SINGLE PROTEIN | ANTAGONIST | CHEMBL211 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3064 | ||
| Human Metabolome Database | HMDB0015170 | ||
| DrugBank | DB01036 | ||
| PubChem: Thomson Pharma | 14801661 | 14777260 | |
| PubChem | 443879 | ||
| LINCS | LSM-5645 | ||
| Nikkaji | J561.859B | ||
| BindingDB | 50165008 | ||
| EPA CompTox Dashboard | DTXSID3023687 | ||
| DrugCentral | 2705 | ||
| Brenda | 169000 | ||
| ChemicalBook | CB4128443 | CB1128442 | |
| Guide to Pharmacology | 360 | ||
| rxnorm | TOLTERODINE TARTRATE | TOLTERODINE | DETROL |
| ChEBI | 9622 | ||
| ZINC | ZINC000000968336 |
